FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 320:1446-1452 June 1, 1989 Number 22 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

In patients with Alzheimer's disease, amyloid fibrils that are aggregates of A4 protein subunits are deposited in the brain. A similar process occurs at an earlier age in persons with Down's syndrome. To investigate the deposition of amyloid in these diseases, we used a radioimmunoassay to measure levels of the amyloid precursor (PreA4) in the serum of 17 patients with Down's syndrome, 15 patients with Alzheimer's disease, and 33 normal elderly controls. The mean (+/- SD) concentration of serum PreA4 was increased 1.5-fold in patients with Down's syndrome (2.49 +/- 1.13 nmol per liter) as compared with that in controls (1.68 +/- 0.49 nmol per liter; P less than 0.007); the levels in patients with Alzheimer's disease were similar to those in controls (1.83 +/- 0.78; P less than 0.98). We also found that the concentration of PreA4 in the brain tissue of two adults with Down's syndrome (100 and 190 pmol per gram) was higher than that in the brain tissue of either 26 patients with Alzheimer's disease (64.4 +/- 17.3 pmol per gram) or 17 elderly controls with neurologic disease (68.5 +/- 26.3 pmol per gram). Immunocytochemical studies of brain tissue from 26 patients with Down's syndrome showed that the deposition of A4 protein amyloid began in these patients approximately 50 years earlier than it began in 127 normal aging subjects studied previously, although the rate of deposition was the same. We conclude that, since the gene for PreA4 is on the long arm of chromosome 21, which is present in triplicate in Down's syndrome, overexpression of this gene may lead to increased levels of PreA4 and amyloid deposition in Down's syndrome. However, since increased levels of PreA4 are not present in Alzheimer's disease, additional factors must account for the amyloid deposition in that disorder.

Source Information

Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.

This article has been cited by other articles:

• Schupf, N., Patel, B., Pang, D., Zigman, W. B., Silverman, W., Mehta, P. D., Mayeux, R. (2007). Elevated Plasma beta-Amyloid Peptide Abeta42 Levels, Incident Dementia, and Mortality in Down Syndrome. Arch Neurol 64: 1007-1013 [Abstract] [Full Text]  
• Sleegers, K., Brouwers, N., Gijselinck, I., Theuns, J., Goossens, D., Wauters, J., Del-Favero, J., Cruts, M., Duijn, C. M. v., Broeckhoven, C. V. (2006). APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 129: 2977-2983 [Abstract] [Full Text]  
• Brouwers, N., Sleegers, K., Engelborghs, S., Bogaerts, V., Serneels, S., Kamali, K., Corsmit, E., Leenheir, E. D., Martin, J.-J., De Deyn, P. P., Broeckhoven, C. V., Theuns, J. (2006). Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brain 129: 2984-2991 [Abstract] [Full Text]  
• Masters, C. L., Beyreuther, K. (2006). Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A{beta} amyloid pathway. Brain 129: 2823-2839 [Abstract] [Full Text]  
• Teipel, S. J., Alexander, G. E., Schapiro, M. B., Moller, H.-J., Rapoport, S. I., Hampel, H. (2004). Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Brain 127: 811-824 [Abstract] [Full Text]  
• Teipel, S. J., Schapiro, M. B., Alexander, G. E., Krasuski, J. S., Horwitz, B., Hoehne, C., Moller, H.-J., Rapoport, S. I., Hampel, H. (2003). Relation of Corpus Callosum and Hippocampal Size to Age in Nondemented Adults With Down's Syndrome. Am. J. Psychiatry 160: 1870-1878 [Abstract] [Full Text]  
• Hill, D. A., Gridley, G., Cnattingius, S., Mellemkjaer, L., Linet, M., Adami, H.-O., Olsen, J. H., Nyren, O., Fraumeni, J. F. Jr (2003). Mortality and Cancer Incidence Among Individuals With Down Syndrome. Arch Intern Med 163: 705-711 [Abstract] [Full Text]  
• SCHUPF, N., Sergievsky, G. H. (2002). Genetic and host factors for dementia in Down's syndrome. Br. J. Psychiatry 180: 405-410 [Abstract] [Full Text]  
• Mizejewski, G. J. (2001). Alpha-fetoprotein Structure and Function: Relevance to Isoforms, Epitopes, and Conformational Variants. Exp. Biol. Med. 226: 377-408 [Abstract] [Full Text]  
• Theuns, J., Van Broeckhoven, C. (2000). Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility. Hum Mol Genet 9: 2383-2394 [Abstract] [Full Text]  
• Skoog, I. (2000). Detection of Preclinical Alzheimer's Disease. NEJM 343: 502-503 [Full Text]  
• Mbella, E. G. M., Bertrand, S., Huez, G., Octave, J.-N. (2000). A GG Nucleotide Sequence of the 3' Untranslated Region of Amyloid Precursor Protein mRNA Plays a Key Role in the Regulation of Translation and the Binding of Proteins. Mol. Cell. Biol. 20: 4572-4579 [Abstract] [Full Text]  
• Stoltzner, S. E., Grenfell, T. J., Mori, C., Wisniewski, K. E., Wisniewski, T. M., Selkoe, D. J., Lemere, C. A. (2000). Temporal Accrual of Complement Proteins in Amyloid Plaques in Down’s Syndrome with Alzheimer’s Disease. Am. J. Pathol. 156: 489-499 [Abstract] [Full Text]  
• HOLLAND, A. J. (2000). Ageing and learning disability. Br. J. Psychiatry 176: 26-31 [Abstract] [Full Text]  
• Lemere, C. A., Grenfell, T. J., Selkoe, D. J. (1999). The AMY Antigen Co-Occurs with A{beta} and Follows Its Deposition in the Amyloid Plaques of Alzheimer's Disease and Down Syndrome. Am. J. Pathol. 155: 29-37 [Abstract] [Full Text]  
• Schuchmann, S., Muller, W., Heinemann, U. (1998). Altered Ca2+ Signaling and Mitochondrial Deficiencies in Hippocampal Neurons of Trisomy 16 Mice: A Model of Down's Syndrome. J. Neurosci. 18: 7216-7231 [Abstract] [Full Text]  
• Weller, R. O., Massey, A., Newman, T. A., Hutchings, M., Kuo, Y.-M., Roher, A. E. (1998). Cerebral Amyloid Angiopathy : Amyloid ß Accumulates in Putative Interstitial FluidDrainage Pathways in Alzheimer's Disease. Am. J. Pathol. 153: 725-733 [Abstract] [Full Text]  
• van Leeuwen, F. W., de Kleijn, D. P., van den Hurk, H. H., Neubauer, A., Sonnemans, M. A., Sluijs, J. A., Köycü, S., Ramdjielal, R. D., Salehi, A., Martens, G. J., Grosveld, F. G., Burbach, J. P. H., Hol, E. M. (1998). Frameshift Mutants of  Amyloid Precursor Protein and Ubiquitin-B in Alzheimer's and Down Patients. Science 279: 242-247 [Abstract] [Full Text]  
• Irizarry, M. C., Soriano, F., McNamara, M., Page, K. J., Schenk, D., Games, D., Hyman, B. T. (1997). Abeta Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse. J. Neurosci. 17: 7053-7059 [Abstract] [Full Text]  
• Holtzman, D. M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D. J., Daniels, S. E., Johnson, R. M., Chen, K., Sun, Y., Carlson, E., Alleva, E., Epstein, C. J., Mobley, W. C. (1996). Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc. Natl. Acad. Sci. USA 93: 13333-13338 [Abstract] [Full Text]  
• Morrison, R. A., McGrath, A., Davidson, G., Brown, J. J., Murray, G. D., Lever, A. F. (1996). Low Blood Pressure in Down's Syndrome: A Link With Alzheimer's Disease?. Hypertension 28: 569-575 [Abstract] [Full Text]  
• Reaume, A. G., Howland, D. S., Trusko, S. P., Savage, M. J., Lang, D. M., Greenberg, B. D., Siman, R., Scott, R. W. (1996). Enhanced Amyloidogenic Processing of the beta -Amyloid Precursor Protein in Gene-targeted Mice Bearing the Swedish Familial Alzheimer's Disease Mutations and a ``Humanized'' Abeta Sequence. J. Biol. Chem. 271: 23380-23388 [Abstract] [Full Text]  
• Tischer, E., Cordell, B. (1996). beta -Amyloid Precursor Protein. LOCATION OF TRANSMEMBRANE DOMAIN AND SPECIFICITY OF gamma -SECRETASE CLEAVAGE. J. Biol. Chem. 271: 21914-21919 [Abstract] [Full Text]  
• De Strooper, B., Craessaerts, K., Dewachter, I., Moechars, D., Greenberg, B., Van Leuven, F., Van Den Berghe, H. (1995). Basolateral Secretion of Amyloid Precursor Protein in Madin-Darby Canine Kidney Cells Is Disturbed by Alterations of Intracellular pH and by Introducing a Mutation Associated with Familial Alzheimer's Disease. J. Biol. Chem. 270: 4058-4065 [Abstract] [Full Text]  
• Bush, A., Pettingell, W., Multhaup, G, d Paradis, M, Vonsattel, J., Gusella, J., Beyreuther, K, Masters, C., Tanzi, R. (1994). Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265: 1464-1467 [Abstract]  
• Hardy, J (1994). ApoE, amyloid, and Alzheimer's disease. Science 263: 454-455  
• Kosik, K. (1992). Alzheimer's disease: a cell biological perspective. Science 256: 780-783 [Abstract]  
• Hardy, J., Higgins, G. (1992). Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185  
• Van Broeckhoven, C, Haan, J, Bakker, E, Hardy, J., Van Hul, W, Wehnert, A, Vegter-Van der Vlis, M, Roos, R. (1990). Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 248: 1120-1122 [Abstract]  
• Levy, E, Carman, M., Fernandez-Madrid, I., Power, M., Lieberburg, I, van Duinen, S., Bots, G., Luyendijk, W, Frangione, B (1990). Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248: 1124-1126 [Abstract]